Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)

The summary for the Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional): The purpose of this limited competition R00 program is to provide physician scientists in blood science with a seamless pathway from a mentored K99/R00 award to investigator independence. Eligible applicants will have matriculated through the Career Pathway to Independence in Blood Science Awards for Physician Scientists ( K99/R00) program for up to three, but no more than five years. The strongest R00 applicants will propose an updated, well-conceived plan for 23 years of independent research support intended to prepare the applicant to subsequently compete for an R01 or equivalent award. These research projects are limited to those that fall within the Division of Blood Diseases and Resources mission. The NIH encourages institutions to recruit and retain individuals from groups currently underrepresented in the biomedical sciences, and to enhance the diversity of the clinician-investigator workforce (NOT-OD-15-053).

Federal Grant Title:	Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HL-23-003
Type of Funding:	Grant
CFDA Numbers:	93.838
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 28th, 2024
Original Application Deadline:	March 28th, 2024
Posted Date:	January 5th, 2022
Creation Date:	January 5th, 2022
Archive Date:	May 3rd, 2024
Total Program Funding:
Maximum Federal Grant Award:	$250,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 24th, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-003.html
Grant Announcement Contact: NIH OER Webmaster
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed); • Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed); • Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required); • Limited Competition: Network Management Core (NEMO) for the Pulmonary Trials Cooperative (...; • Advancing Novel Research Models to Study Idiopathic Pulmonary Fibrosis (U01 Clinical Trial...; • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models; • Lung Response to Inhaled Highly Toxic Chemicals; • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health: • BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R...; • Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorde...; • BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R...; • International Research in Infectious Diseases (R01 Clinical Trial Not Allowed); • Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IM...